In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71

Enterovirus 71 (EV71) is the causative agent of hand foot and mouth disease (HFMD) and can also cause fatal neurological complications for which currently there is no vaccine or approved antiviral drug. Despite suggestions that heparan sulfate (HS)-like compounds are effective antivirals against var...

Full description

Bibliographic Details
Main Authors: Pourianfar, Hamid Reza, Poh, Chit Laa *, Fecondo, John, Grollo, Lara
Format: Article
Published: Elsevier 2012
Subjects:
Online Access:http://eprints.sunway.edu.my/223/
_version_ 1848801776603496448
author Pourianfar, Hamid Reza
Poh, Chit Laa *
Fecondo, John
Grollo, Lara
author_facet Pourianfar, Hamid Reza
Poh, Chit Laa *
Fecondo, John
Grollo, Lara
author_sort Pourianfar, Hamid Reza
building SU Institutional Repository
collection Online Access
description Enterovirus 71 (EV71) is the causative agent of hand foot and mouth disease (HFMD) and can also cause fatal neurological complications for which currently there is no vaccine or approved antiviral drug. Despite suggestions that heparan sulfate (HS)-like compounds are effective antivirals against various viruses, no research has been undertaken to examine their effects upon EV71. Therefore, this study aimed to investigate the in vitro anti-EV71 effect of HS mimetics (heparin, heparan sulfate, and pentosan polysulfate). The results revealed that all of the compounds exhibited significant antiviral actions (p < 0.05) against EV71 at concentrations less than 250 μg/mL, compared to virus control and positive control, ribavirin. Among the compounds, heparin exhibited the most potent antiviral activity, as 7.81 μg/mL of it prevented the infection by more than 90% (p < 0.05). Assays to reveal the mode of action revealed that all of the compounds were capable of exerting antiviral activity through hindrance of viral attachment to the cells. In addition, some of the compounds could inhibit viral replication when added to cells 1 h before infection, but none significantly reduced viral penetration. Overall, this research revealed that HS mimetic compounds could inhibit EV71 infection, and that HS may be involved in EV71–host cell interactions, as the virus binding to the host cells was significantly hindered by the HS-like compounds but not by ribavirin. Thus, further investigations to discover the molecular mechanisms underlying the anti-EV71 action of HS-like compounds are warranted.
first_indexed 2025-11-14T21:12:50Z
format Article
id sunway-223
institution Sunway University
institution_category Local University
last_indexed 2025-11-14T21:12:50Z
publishDate 2012
publisher Elsevier
recordtype eprints
repository_type Digital Repository
spelling sunway-2232019-04-22T05:08:58Z http://eprints.sunway.edu.my/223/ In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71 Pourianfar, Hamid Reza Poh, Chit Laa * Fecondo, John Grollo, Lara QR Microbiology RM Therapeutics. Pharmacology Enterovirus 71 (EV71) is the causative agent of hand foot and mouth disease (HFMD) and can also cause fatal neurological complications for which currently there is no vaccine or approved antiviral drug. Despite suggestions that heparan sulfate (HS)-like compounds are effective antivirals against various viruses, no research has been undertaken to examine their effects upon EV71. Therefore, this study aimed to investigate the in vitro anti-EV71 effect of HS mimetics (heparin, heparan sulfate, and pentosan polysulfate). The results revealed that all of the compounds exhibited significant antiviral actions (p < 0.05) against EV71 at concentrations less than 250 μg/mL, compared to virus control and positive control, ribavirin. Among the compounds, heparin exhibited the most potent antiviral activity, as 7.81 μg/mL of it prevented the infection by more than 90% (p < 0.05). Assays to reveal the mode of action revealed that all of the compounds were capable of exerting antiviral activity through hindrance of viral attachment to the cells. In addition, some of the compounds could inhibit viral replication when added to cells 1 h before infection, but none significantly reduced viral penetration. Overall, this research revealed that HS mimetic compounds could inhibit EV71 infection, and that HS may be involved in EV71–host cell interactions, as the virus binding to the host cells was significantly hindered by the HS-like compounds but not by ribavirin. Thus, further investigations to discover the molecular mechanisms underlying the anti-EV71 action of HS-like compounds are warranted. Elsevier 2012-10 Article PeerReviewed Pourianfar, Hamid Reza and Poh, Chit Laa * and Fecondo, John and Grollo, Lara (2012) In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71. Virus Research, 169 (1). pp. 22-29. ISSN 0168-1702 (print ISSB); 1872-7492 (e ISSN) http://dx.doi.org/10.1016/j.virusres.2012.06.025
spellingShingle QR Microbiology
RM Therapeutics. Pharmacology
Pourianfar, Hamid Reza
Poh, Chit Laa *
Fecondo, John
Grollo, Lara
In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71
title In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71
title_full In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71
title_fullStr In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71
title_full_unstemmed In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71
title_short In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71
title_sort in vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against enterovirus 71
topic QR Microbiology
RM Therapeutics. Pharmacology
url http://eprints.sunway.edu.my/223/
http://eprints.sunway.edu.my/223/